With the help of a routine clinical case, we highlighted the difference between two of the best asthma guidelines available at the time regarding therapeutic suggestions for the so-called “third step” for school-age asthmatic children. We have analyzed the scientific evidence that each of the two guidelines brings to support their position. Finally, we have motivatedly solved the clinical scenario. However, the question of disagreement between two guidelines remains unresolved. This can lead to unjustified differences in the management of schoolchildren with persistent asthma.
Miceli Sopo, S., Bersani, G., Del Vescovo, E., Gelsomino, M., Disagreement between guidelines regarding the third step of asthma drug therapy for school-age children, <<ALLERGOLOGIA ET IMMUNOPATHOLOGIA>>, 2020; 48 (6): 789-791. [doi:10.1016/j.aller.2019.12.004] [http://hdl.handle.net/10807/167062]
Disagreement between guidelines regarding the third step of asthma drug therapy for school-age children
Miceli Sopo, Stefano
Conceptualization
;Bersani, GiuseppeFormal Analysis
;Del Vescovo, EsterSupervision
;Gelsomino, MariannitaWriting – Original Draft Preparation
2020
Abstract
With the help of a routine clinical case, we highlighted the difference between two of the best asthma guidelines available at the time regarding therapeutic suggestions for the so-called “third step” for school-age asthmatic children. We have analyzed the scientific evidence that each of the two guidelines brings to support their position. Finally, we have motivatedly solved the clinical scenario. However, the question of disagreement between two guidelines remains unresolved. This can lead to unjustified differences in the management of schoolchildren with persistent asthma.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
